Prostaglandins in circulatory disorders.
D000804:Angiotensin II / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology; D001095:Arachidonic Acids / Q000096:biosynthesis; D001161:Arteriosclerosis / Q000517:prevention & control; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects; D004032:Diet; D004176:Dipyridamole / Q000494:pharmacology / Q000627:therapeutic use; D004537:Eicosanoic Acids / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000378:metabolism; D010974:Platelet Aggregation; D011453:Prostaglandins / Q000172:deficiency / Q000378:metabolism*; D013927:Thrombosis / Q000517:prevention & control; D013931:Thromboxanes / Q000096:biosynthesis; D014652:Vascular Diseases / Q000097:blood / Q000378:metabolism*
D000959:Antihypertensive Agents; D001095:Arachidonic Acids; D004537:Eicosanoic Acids; D011453:Prostaglandins; D013931:Thromboxanes; D000804:Angiotensin II; D004176:Dipyridamole; D001241:Aspirin